NEW YORK (GenomeWeb News) – In order to address what it describes as a need for more biomarker-based products aimed at predicting cancer and its advancement and predicting patient response, the National Cancer Institute has put out a new grants program to fund biomarker development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.